ARTICLE | Finance
Eikon to double headcount with $518M series B
Roger Perlmutter-led super-resolution microscopy company has unveiled an expanded C-suite
January 7, 2022 12:46 AM UTC
With more than $668 million raised since its 2020 founding, Roger Perlmutter-helmed Eikon is building out its talent base to turn dynamic molecular insights from living cells into better targets and therapeutics.
Eikon Therapeutics Inc. plans to use the proceeds from its $517.8 million series B round, announced Thursday, to double in size in 2022, and “rapidly scale operations” to industrialize its platform and advance its pipeline, the Hayward, Calif.-based company said in an emailed statement. ...